Shuttle Pharmaceuticals Holdings, Inc. [Rocket]

Overview

Shuttle Pharmaceuticals Holdings, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/10/2023	8-K	Other Events, Financial Statements and Exhibits  Interactive Data
10/05/2023	8-K	Entered into consulting agreement
08/24/2023	424B3	Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/18/2023	4	Dritschilo Anatoly (CEO and Chairman) has filed a Form 4 on Shuttle Pharmaceuticals Holdings, Inc.
08/15/2023	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/03/2023	8-K	Other Events, Financial Statements and Exhibits  Interactive Data

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20
Revenues	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0
Research and development	1.5	1.0	0.2
General and administrative	0.2	0.0	0.1
EBIT	-1.7	-1.1	-0.2
Pre-tax income	-3.0	-1.2	-0.8
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-3.1	-1.3	-0.9

Diluted EPS	($0.30)	($0.13)	($0.10)
Shares outstanding (diluted)	10.4	9.3	9.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy